Rift valley fever prevention

Revision as of 16:17, 17 July 2021 by Aakash Hans (talk | contribs) (→‎Prevention)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Rift valley fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Rift valley fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rift valley fever prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rift valley fever prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rift valley fever prevention

CDC on Rift valley fever prevention

Rift valley fever prevention in the news

Blogs on Rift valley fever prevention

Directions to Hospitals Treating Rift valley fever

Risk calculators and risk factors for Rift valley fever prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Aakash Hans, MD[2]

Overview

Prevention of Rift valley fever is key for African nations because of the deep socio-economic impact the disease has in these areas. The loss of livestock and subsequent infections in humans catering to these animals has reverberating affects for that areas economies. The mainstay of prevention is to avoid exposure to animals exhibiting symptoms of infection and to reduce mosquito breeding around livestock and farms.

Prevention

Primary Prevention

  • Avoiding exposure to infected or unwell livestock.
  • Separating and isolating animals with symptoms from the rest of the herd will help in curtailing the spread amongst the animals, which in turn will decrease the risk of transmission of the virus from animals to humans.
  • Effective mosquito control is pertinent in reducing transmission to humans.
  • Many vaccines have been developed over the course of history, with the major challenge being, formulating a one-shot vaccine for livestock. Few vaccines are undergoing testing to gain approval for use in animals. [1]

Secondary prevention

There are no established measures for secondary prevention of this disease.

References

  1. Njenga MK, Njagi L, Thumbi SM, et al. Randomized controlled field trial to assess the immunogenicity and safety of rift valley fever clone 13 vaccine in livestock. PLoS neglected tropical diseases. 2015 Mar;9(3):e0003550.

Template:WH Template:WS